story of the week
Risk of Venous Thromboembolism in Patients With Acne Receiving Spironolactone vs Tetracycline-Class Antibiotics
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Journal of the American Academy of Dermatology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Spironolactone use for acne is not associated with an increased risk of venous thromboembolism: A matched, retrospective cohort study
J Am Acad Dermatol 2023 Feb 25;[EPub Ahead of Print], A Shields, K Flood, JS BarbieriFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.